Muutke küpsiste eelistusi

Behavioral Neurobiology of Psychedelic Drugs 2018 ed. [Kõva köide]

Edited by , Edited by , Edited by
  • Formaat: Hardback, 430 pages, kõrgus x laius: 235x155 mm, kaal: 828 g, 158 Illustrations, color; 38 Illustrations, black and white; X, 430 p. 196 illus., 158 illus. in color., 1 Hardback
  • Sari: Current Topics in Behavioral Neurosciences 36
  • Ilmumisaeg: 11-Apr-2018
  • Kirjastus: Springer-Verlag Berlin and Heidelberg GmbH & Co. K
  • ISBN-10: 3662558785
  • ISBN-13: 9783662558782
Teised raamatud teemal:
  • Kõva köide
  • Hind: 215,47 €*
  • * hind on lõplik, st. muud allahindlused enam ei rakendu
  • Tavahind: 253,49 €
  • Säästad 15%
  • Raamatu kohalejõudmiseks kirjastusest kulub orienteeruvalt 2-4 nädalat
  • Kogus:
  • Lisa ostukorvi
  • Tasuta tarne
  • Tellimisaeg 2-4 nädalat
  • Lisa soovinimekirja
Behavioral Neurobiology of Psychedelic Drugs 2018 ed.Suurem pilt
  • Formaat: Hardback, 430 pages, kõrgus x laius: 235x155 mm, kaal: 828 g, 158 Illustrations, color; 38 Illustrations, black and white; X, 430 p. 196 illus., 158 illus. in color., 1 Hardback
  • Sari: Current Topics in Behavioral Neurosciences 36
  • Ilmumisaeg: 11-Apr-2018
  • Kirjastus: Springer-Verlag Berlin and Heidelberg GmbH & Co. K
  • ISBN-10: 3662558785
  • ISBN-13: 9783662558782
Teised raamatud teemal:
Püsilink: https://www.kriso.ee/db/9783662558782.html
This volume brings together the latest basic and clinical research examining the effects and underlying mechanisms of psychedelic drugs. Examples of drugs within this group include LSD, psilocybin, and mescaline. Despite their structural differences, these compounds produce remarkably similar experiences in humans and share a common mechanism of action.  Commonalities among the substances in this family are addressed both at the clinical and phenomenological level and at the basic neurobiological mechanism level. To the extent possible, contributions relate the clinical and preclinical findings to one another across species. The volume addresses both the risks associated with the use of these drugs and the potential medical benefits that might be associated with these and related compounds.

Arvustused

This book brings together the latest basic and clinical research into the underlying mechanism of action, effects, and possible clinical uses of psychedelic drugs. It brings together current knowledge regarding this class of drugs pharmacology, neurobiological effects, subjective experience, and therapeutic effects. It brings together preclinical and clinical data, which will be of interest to anyone involved with or curious about this category of drugs. (Michael Easton, Doody's Book Reviews, September, 2018)

Chemistry and Structure-Activity Relationships of Psychedelics
1(44)
David E. Nichols
Hallucinogens and Serotonin 5-HT2A Receptor-Mediated Signaling Pathways
45(30)
Juan F. Lopez-Gimenez
Javier Gonzalez-Maeso
Effects of Hallucinogens on Neuronal Activity
75(32)
L. Llado-Pelfort
P. Celada
M.S. Riga
E. Troyano-Rodriguez
N. Santana
F. Artigas
Interactions of Hallucinogens with the Glutamatergic System: Permissive Network Effects Mediated Through Cortical Layer V Pyramidal Neurons
107(30)
Gerard J. Marek
The Effects of Hallucinogens on Gene Expression
137(22)
David A. Martin
Charles D. Nichols
Effect of Hallucinogens on Unconditioned Behavior
159(42)
Adam L. Halberstadt
Mark A. Geyer
Hallucinogens in Drug Discrimination
201(20)
Lisa E. Baker
Phenomenology, Structure, and Dynamic of Psychedelic States
221(36)
Katrin H. Preller
Franz X. Vollenweider
Serotonergic Hallucinogen-Induced Visual Perceptual Alterations
257(26)
Michael Kometer
Franz X. Vollenweider
New World Tryptamine Hallucinogens and the Neuroscience of Ayahuasca
283(30)
Dennis McKenna
Jordi Riba
Experimental Psychosis Research and Schizophrenia---Similarities and Dissimilarities in Psychopathology
313(20)
Leo Hermle
Rainer Kraehenmann
A Review of Hallucinogen Persisting Perception Disorder (HPPD) and an Exploratory Study of Subjects Claiming Symptoms of HPPD
333(28)
John H. Halpern
Arturo G. Lerner
Torsten Passie
Therapeutic Applications of Classic Hallucinogens
361(32)
Michael P. Bogenschutz
Stephen Ross
Classic Hallucinogens and Mystical Experiences: Phenomenology and Neural Correlates
393
Frederick S. Barrett
Roland R. Griffiths
Erratum to: Phenomenology, Structure, and Dynamic of Psychedelic States El
1
Katrin H. Preller
Franz X. Vollenweider